As of May 29
| -0.02 / -0.50%|
The 4 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 13.00 and a low estimate of 7.00. The median estimate represents a +77.22% increase from the last price of 3.95.
The current consensus among 4 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.